Dr. Ganesh Jadhav

Dr. Ganesh Jadhav

Senior Consultant 

41 Years of Experience

Radiation Oncologist

MBBS, MD, DNB, MNAMS, FAGE, FICRO, Fellowship

Reg. No.:22842, Delhi Medical Council

Confirm Your Consultation With Dr. Ganesh Jadhav

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Ganesh Jadhav

  • Dr. Ganesh K Jadhav is a renowned Radiation Oncologist with over 41 years of experience.
  • He is proficient in advanced radiation techniques such as Stereotactic Radiotherapy, Radiosurgery, Intensity-Modulated Radiotherapy (IMRT), 3D Brachytherapy, Stereotactic Body Radiotherapy (SBRT), and Image-Guided Radiotherapy (IGRT).
  • His clinical expertise includes Immunotherapy, Hormone Therapy, Breast Cancer Surgery, Colonoscopy, and Ocular Oncology.
  • He specializes in treating various cancers including Lung Cancer, Blood Cancer, Hepatobiliary Cancer, Gastrointestinal Cancer, Colorectal Cancer, Urologic Oncology, and Gynecologic Cancer.
  • He completed his MBBS from Karnataka University in 1984.
  • He earned his MD in Radiotherapy from Mangalore University in 1990.
  • He also holds a DNB from the National Board of Examination, New Delhi.
  • Dr. Jadhav is a Diplomate of the National Board and has received fellowships from the UICC and the Commonwealth (UK).
  • He has published numerous research papers in reputed national and international journals.

Confirm Your Consultation With Dr. Ganesh Jadhav

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, Karnataka University, India, 1984
  • MD (Radiotherapy) Mangalore University, Karnataka, India, 1990
  • DNB, National Board of Examination, New Delhi
  • MNAMS
  • Fellowship of Academy of General Education (FAGE)
  • FICRO
  • Fellow of Commonwealth University, UK
  • Fellowships - Union for International Cancer Control (UICC)

OPD Schedule Of Dr. Ganesh Jadhav

Book Appointment
  • “Potential for differentiation of glioma recurrence from radionecrosis using integrated 18F-fluoroethyl-L-tyrosine (FET) positron emission tomography/magnetic resonance imaging: A prospective evaluation” by Neurology India in 2017
  • “Vincristine (Vinca-alkaloid) as a sclerosing agent for malignant pleural effusions” by Acta Oncologica (Stockholm, Sweden) in 1999
  • “Possible role of glutathione in predicting Radiotherapy response of cervix cancer” by International Journal of Radiation Oncology, biology, physics in 1998
  • “Multiparametric evaluation in differentiating glioma recurrence from treatment induced-necrosis using simultaneous 18F-FDG-PET/MRI: A single-institution retrospective study” by American Journal of Neuroradiology in 2017
  • “A retrospective study of outcomes in subjects of head and neck cancer treated with hyperbaric oxygen therapy for radiation-induced osteoradionecrosis of the mandible at a tertiary care center: An Indian experience” by Indian Journal of Otolaryngology and head and neck surgery: Official publication of the Association of Otolaryngologists of India in 2013
  • Indian Medical Association (IMA)
  • National Academy of Medical Sciences (MNAMS)
  • Association of Radiation Oncologists of India (AROI)